Molecular Partners AG annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Molecular Partners AG Capital Expenditures (CapEx) Growth & History (MOLN)
Molecular Partners AG's capital expenditures (capex) was CHF714,000 for fiscal 2025.
View full Molecular Partners AG company overviewMolecular Partners AG annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF714,000 | CHF9,000 | +1.28% |
| 2024 | 2024-12-31 | CHF705,000 | CHF130,000 | +22.61% |
| 2023 | 2023-12-31 | CHF575,000 | −CHF602,000 | −51.15% |
| 2022 | 2022-12-31 | CHF1.2M | CHF244,000 | +26.15% |
| 2021 | 2021-12-31 | CHF933,000 | −CHF518,000 | −35.70% |
| 2020 | 2020-12-31 | CHF1.5M | CHF420,000 | +40.74% |
| 2019 | 2019-12-31 | CHF1.0M | — | — |
Molecular Partners AG quarterly capital expenditures (capex)
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | CHF139,000 | CHF2,000 | +1.46% |
| Q3 2025 | 2025-09-30 | CHF31,000 | — | — |
| Q2 2025 | 2025-06-30 | CHF96,000 | — | — |
| Q1 2025 | 2025-03-31 | CHF448,000 | — | — |
| Q4 2024 | 2024-12-31 | CHF137,000 | — | — |
Molecular Partners AG capital expenditures (capex) trends
Over the last five fiscal years, Molecular Partners AG's capital expenditures (capex) decreased from CHF1.5M to CHF714,000, a change of −CHF737,000. The latest reported quarter, Q4 2025, shows CHF139,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Molecular Partners AG source filings ↗